Breathing during sleep was monitored in 8 diabetic patients with objective evidence of autonomic neuropathy and in 8 diabetic patients without neuropathy. Thirty or more periods of apnoea lasting 10 seconds or longer during one night's sleep were demonstrated in 3 of the diabetic patients with autonomic neuropathy. Such apnoeic periods may be related to the high incidence of cardiorespiratory arrests-reported in such patients, particularly in association with anaesthesia or pneumonia.
Introduction
Recurrent periods of apnoea during sleep have been described in a variety of conditions (Guilleminault et al. 1978) , and indicate that previously unrecognized abnormalities in the control of breathing may become apparent when wakefulness is lost. Such apnoeic periods are uncommon in normal subjects and 30 or more episodes during 7 hours of sleep are usually regarded as abnormal (Guilleminault et al. 1976) , although a strict division between normal and abnormal numbers of nocturnal apnoeas is probably artificial (Block et al. 1979) .
Unexpected cardiorespiratory arrests have been reported in diabetic patients with autonomic neuropathy (Page & Watkins 1978 , Srinivasan & Sanders 1978 , Garcia-Bunuel 1978 . Many of these have occurred in association with anaesthesia or pneumonia and this suggests that abnormal ventilatory control was present.
This paper describes the studies which we have performed to investigate the possibility that diabetic patients with autonomic neuropathy have episodes of apnoea during sleep.
Methods
Eight patients with diabetes mellitus of at least three years' duration, who had objective evidence of autonomic neuropathy, have been studied together with 8 diabetic patients with similar duration of diabetes, but without neuropathy, matched for age, each within seven years. All patients were being treated with subcutaneous insulin. They were in a stable clinical state with well controlled diabetes and were not receiving respiratory depressant drugs. None of the patients had abnormal neurological signs suggesting central nervous system lesions. Of the patients with autonomic neuropathy, 6 had diabetic retinopathy, 4 had diabetic nephropathy, 2 had peripheral vascular disease and I had diabetic amyotrophy. Of those without neuropathy, I patient had minimal retinopathy and I had peripheral vascular disease. No patient had clinical or physiological evidence of airflow obstruction.
Autonomic neuropathy was diagnosed if one or more of the following tests was abnormal. (a) Blood pressure and posture: Blood pressure and pulse were recorded for 10 minutes while the patient lay relaxed on a couch. The patient then stood up, and blood pressure and pulse rate were monitored for a further 5 minutes. A drop in systolic pressure of 20 mmHg or diastolic pressure of 15 mmHg was considered abnormal; this was confirmed by a failure of acceleration of pulse rate. (b) Respiratory influence on heart rate: The electrocardiogram (ECG) was recorded continuously during maximal deep breathing procedures. Variation in heart rate between inspiration and expiration of less than 10% was considered abnormal (Sundkvist et al. 1979). (c) Heart rate response to standing: Immediate heart rate response to standing was estimated from a continuous recording of the ECG. The intervals between 2 R waves of the QRS complex at the 15th and 30th beat after standing were measured. A ratio of R-R intervals at the 15th to 30th beats of 1.0 or less was considered abnormal (Ewing et al. 1978) .
Patients slept in a single room where they could be observed closely at night. Rib cage and abdominal wall movements were monitored by pairs of magnetometer coils. Airflow at the nose and mouth was sensed by thermistors, and a continuous recording of the ECG was made. Traces were analysed for periods of apnoea lasting 10 seconds or longer during sleep. Apnoeas were classified as central (absent airflow with no rib cage or abdominal movement), obstructive (absent airflow with paradoxical inward rib cage movement) or mixed (central becoming obstructive) (Sharp et al. 1980). Blood glucose was estimated on three occasions through the night in one patient with neuropathy (RW) using the Analox GM5 blood sugar analyser. Samples were taken from an indwelling venous cannula without disturbing the patient.
Results
Clinical details of the 16 patients are shown in Table 1 . Three of the patients with objective evidence of autonomic neuropathy were found to have more than 30 periods of apnoea during one night's sleep ( Figure 1 ). Two patients had mainly central apnoeas while the third had predominantly obstructive apnoeas ( Table 2 ). The longest period of apnoea was of obstructive type in a 62-year-old man (PP) and lasted 108 seconds (Figure 2) . The greatest number of apnoeic periods in a diabetic patient without autonomic neuropathy was 6. None of the patients reported any disturbance of breathing and none had complained of daytime sleepiness. Bradycardia was observed only during the long obstructive apnoeas in patient PP, and even then was not marked, falling to a minimum of 57 per minute followed by a tachycardia of96 per minute (Figure 2) . Three blood glucose measurements during the night were made on one patient (RW) who developed sleep apnoea; the blood glucose did not fall below 5.0 mmol/l. Diabetic complications were much more common in diabetic patients with autonomic neuropathy but were not confined to those patients with abnormally frequent nocturnal apnoeas. 
Discussion
The presence of recurrent apnoeas during sleep indicates that changes in the control of breathing are occurring when wakefulness is lost. Our findings that an abnormal number of apnoeas occurred during sleep in 3 out of 8 diabetic patients with autonomic neuropathy suggests that such patients have abnormal ventilatory control which might be related to reports of unexpected cardiorespiratory arrests (Page & Watkins 1978 , Srinivasan & Sanders 1978 , Garcia-Bunuel 1978 .
Daytime hypersomno1ence (Orr et al. 1979) , the development of pulmonary hypertension in response to recurrent episodes of nocturnal hypoxia (Motta et al. 1978) and the occurrence of bradycardia or cardiac arrhythmias (Tilkian et al. 1977) ,are all common in patients with sleep apnoea. However, none of these was seen in our diabetic patients who developed nocturnal apnoeas. Autonomic denervation of the heart may have prevented the development of extreme bradycardia during long apnoeic periods (Guilleminault et al. 1977) . The absence of day-time hypersomnolence and pulmonary hypertension probably reflects the smaller number of apnoeas in our patients compared with the large numbers, often several hundreds, which occur in patients with the classical sleep apnoea syndromes (Guilleminault et al. 1978) . Nevertheless, we believe that the number and length of apnoeas reported must be regarded as abnormal.
Several mechanisms might explain the occurrence of sleep apnoea in our patients. Chemoreceptor denervation or vagal denervation of the lungs might result in defective respiratory reflexes. Alternatively, vascular damage to the respiratory centres might explain the disordered ventilatory control. However, none of the diabetic patients who developed sleep apnoea had clinical evidence of brainstem dysfunction, although circumscribed lesions of the respiratory centres might occur in the absence of other neurological signs. Lesions in this area are thought to be responsible for sleep apnoea in the Shy-Drager syndrome (Lehrman et al. 1978 ,Bannister 1979 .Nocturnal hypoglycaemia is not uncommon in diabetic patients (Gale & Tattersall 1979) , but seems unlikely to be a cause of repeated short apnoeas. . In one of the patients who developed apnoeas during sleep, blood glucose estimations during the night failed to demonstrate hypoglycaemia.
The occurrence of sleep apnoea in diabetic patients with autonomic neuropathy may have serious consequences. Patients with sleep apnoea have an increased risk of sudden death at night (Guilleminault et al. 1978 ). The apnoeic periods described might be the basis of the cardiorespiratory arrests found in diabetics with autonomic neuropathy when additional factors such as respiratory depressant drugs in anaesthesia or hypoxia during respiratory illness are present. It has been suggested (Page & Watkins 1978)that a diminished ventilatory response to hypoxia secondary to denervation of chemoreceptors might be involved in the arrests, but recent studies (Flenley 1979) suggest that the hypoxic ventilatory response is not affected by the autonomic neuropathy in diabetic patients. It is possible, also, that recurrent nocturnal hypoxaemia might accelerate the progression of diabetic complications and contribute to the poor prognosis of these patients (Ewing et al. 1976) .
Diabetic patients with autonomic neuropathy who developed sleep apnoea may form a subgroup at high risk of sudden death during anaesthesia or pneumonia. Monitoring of nasal and oral airflow is a simple method for detecting apnoea and would indicate which patients were at greatest risk. However, all patients with autonomic neuropathy, particularly those with underlying cardiorespiratory disorders, should be observed carefully during and after the use of respiratory depressant drugs or anaesthesia.
